Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Etanercept Long-Term Extension in Ankylosing Spondylitis
NCT00421980Phase 3Completed
- Sponsor
- Pfizer
- Start
- Jun 2002
- Modality
- Fc-Fusion Proteins
- Countries
- 1
01
Overview
A Phase 3 trial of etanercept in ankylosing spondylitis (AS), sponsored by Pfizer. Started Jun 2002; status: completed.
02
Drugs
etanercept
03
Conditions
ankylosing spondylitis (AS)
Beyond the preview
Go deeper on NCT00421980.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00421980.